Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof

Inactive Publication Date: 2007-12-13
UAB RES FOUND
View PDF3 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0012] Further disclosed is a method of ameliorating one or more effects of an aortic cross clamp used during surgery in a subject in need thereof, comprising administering estrogen in

Problems solved by technology

The traumatic injury can involve severe blood loss.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof
  • Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof
  • Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

1. Example 1

Female Sex Hormones Regulate Macrophage Function after Trauma-Hemorrhage and Prevent Increased Death Rate from Subsequent Sepsis

[0118] Circulating female sex hormones were reduced by ovariectomy of 8-week-old female CBA / J mice. Two weeks afterward, ovariectomy and proestrus sham-ovariectomy mice were subjected to laparotomy (i.e., soft tissue trauma) and hemorrhagic shock (35±5 mm Hg for 90 minutes, then resuscitated) or sham operation. Two hours afterward, splenic and peritoneal MΦ and Kupffer cells were isolated and cytokine production was assessed. In a second series of experiments, animals were subjected to sepsis by cecal ligation and puncture at 24 hours after trauma-hemorrhage or sham operation, and survival was assessed.

[0119] Release of interleukin-1 and interleukin-6 by splenic and peritoneal MΦ from proestrus mice was maintained after trauma-hemorrhage, whereas release of interleukin-1 and interleukin-6 by M from ovariectomized mice was depressed by approxim...

example 2

2. Example 2

The Female Reproductive Cycle is an Important Variable in the Response to Trauma-Hemorrhage

[0161] Although immune functions in proestrus females are maintained after hemorrhage as opposed to decreased responses in males, it has previously been unknown whether such a sexual dimorphism also exists with regard to cardiovascular and hepatocellular functions under those conditions. To study this, male and female (estrus and proestrus) rats underwent a 5-cm midline laparotomy and were bled to and maintained at a mean blood pressure of 40 mmHg until 40% of the maximal bleed-out volume was returned in the form of Ringer lactate (RL). Rats were then resuscitated with four times the shed blood volume with RL. At 24 h thereafter, cardiac index; heart performance; hepatocellular function; and plasma estradiol, testosterone, and prolactin levels were measured. Cardiovascular and hepatocellular functions were depressed in males and estrus females (p<0.05) but were not depressed in pr...

example 3

3. Example 3

Estradiol Administration after Trauma-Hemorrhage Improves Cardiovascular and Hepatocellular Functions in Male Animals

[0209] Studies indicate that gender difference exists in the immune and cardiovascular responses to trauma-hemorrhage, and that male sex steroids appear to be responsible for producing immune and organ dysfunction, but it was previously unknown if sex steroids produce any salutary effects on the depressed cellular and organ functions in males following trauma and hemorrhage.

[0210] Adult male Sprague-Dawley rats underwent a midline laparotomy (i.e., trauma induction), and were bled to and maintained at a mean arterial pressure of 40 mmHg until 40% of the maximum bleed-out volume was returned in the form of Ringer's lactate (RL). Animals were then resuscitated with RL at 4 times the shed blood over 60 minutes. 17β-Estradiol (50 mg / kg) or an equal volume of vehicle was injected subcutaneously 15 minutes before the end of resuscitation. The maximal rate of v...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to view more

Abstract

Disclosed are methods and materials for treating or preventing complications due to traumatic injuries using estrogen or derivatives thereof.

Description

I. CROSS REFERENCE TO RELATED APPLICATION [0001] This application claims priority to U.S. Provisional Application 60 / 802,352 filed on May 22, 2006, and this application is incorporated herein in its entirety by reference.II. ACKNOWLEDGEMENT [0002] This invention was made with government support under grant number W81XWH-05-2-0046 awarded by the DARPA. The United States Government has certain rights in this invention.III. BACKGROUND OF THE INVENTION [0003] Hemorrhage is the most common cause of death among injured or treated individuals including those who die prior to reaching care, who die in emergency medical care, e.g. emergency room, or who die in the operating room (Holcomb 1997; Holcomb 1999). The most common causes of death of individuals in post-operative critical care are those involving sequellae of poorly controlled hemorrhage and shock. In the prehospital setting, most internal bleeding is not accessible for direct intervention. In the hospital setting, there are sources...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/56A61K31/721A61P9/00C12N5/00
CPCA61K31/56C12N2501/392A61K31/721A61K31/565A61P7/00A61P9/00
Inventor CHAUDRY, IRSHADHUBBARD, WILLIAM J.BA, ZHENG FENG
Owner UAB RES FOUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products